Nonstructural nipah virus C protein regulates both the early host proinflammatory response and viral virulence

Journal of Virology

Volumn 86, Issue 19, 2012, Pages 10766-10775

  Mathieu, Cyrille ^a,b   Guillaume, Vanessa ^a,b   Volchkova, Valentina A ^a,b   Pohl, Christine ^a,b   Jacquot, Frederique ^c   Looi, Ren Yih ^d   Wong, Kum Thong ^d   Legras Lachuer, Catherine ^b,e   Volchkov, Viktor E ^a,b   Lachuer, Joel ^b,e,f   Horvat, Branka ^a,b  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c INSERM   (France)

^d UNIVERSITY OF MALAYA   (Malaysia)

^e ProfileXpert   (France)

^f CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; CYTOKINE; GRANULOCYTE CHEMOTACTIC PROTEIN 2; INTERLEUKIN 1BETA; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; NIPAH VIRUS ANTIBODY; NONSTRUCTURAL NIPAH VIRUS DELTA C PROTEIN; TRANSCRIPTOME; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; GENE EXPRESSION; GENETIC TRANSFECTION; HAMSTER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLAMMATION; INFLAMMATORY CELL; LETHALITY; LEUKOCYTE MIGRATION; NIPAH VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; TRANSCRIPTOMICS; VIRUS ATTENUATION; VIRUS GENE; VIRUS IMMUNITY; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; CRICETINAE; CYTOKINES; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, VIRAL; HEK293 CELLS; HUMANS; INFLAMMATION; MESOCRICETUS; MICROCIRCULATION; NIPAH VIRUS; PHOSPHOPROTEINS; RECOMBINANT PROTEINS; TIME FACTORS; UMBILICAL VEINS; VIRAL PROTEINS; VIRULENCE;

ANIMALIA; CRICETINAE; NIPAH VIRUS; PARAMYXOVIRIDAE; PTEROPODIDAE;

EID: 84867667482     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01203-12     Document Type: Article

References (63)

1. Baron MD, Barrett T. 2000. Rinderpest viruses lacking the C and V proteins show specific defects in growth and transcription of viral RNAs. J. Virol. 74:2603-2611.
2. Basler CF. 11 April 2012. Nipah and Hendra virus interactions with the innate immune system. Curr. Top. Microbiol. Immunol. [Epub ahead of print.]
3. Bossart KN, Wang LF, Eaton BT, Broder CC. 2001. Functional expression and membrane fusion tropism of the envelope glycoproteins of Hendra virus. Virology 290:121-135.
4. Bromley SK, Mempel TR, Luster AD. 2008. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat. Immunol. 9:970-980.
5. Bussolino F, et al. 1989. Granulocyte- and granulocyte-macrophagecolony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 337:471-473.
6. Chadha MS, et al. 2006. Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg. Infect. Dis. 12:235-240.
7. Chan YP, Chua KB, Koh CL, Lim ME, Lam SK. 2001. Complete nucleotide sequences of Nipah virus isolates from Malaysia. J. Gen. Virol. 82:2151-2155.
8. Childs K, et al. 2007. mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359:190-200.
9. Chua KB, et al. 2000. Nipah virus: a recently emergent deadly paramyxovirus. Science 288:1432-1435.
10. Chua KB, et al. 2002. Isolation of Nipah virus from Malaysian Island flying-foxes. Microbes Infect. 4:145-151.
11. Chua KB, et al. 2000. High mortality in Nipah encephalitis is associated with presence of virus in cerebrospinal fluid. Ann. Neurol. 48:802-805.
12. Ciancanelli MJ, Volchkova VA, Shaw ML, Volchkov VE, Basler CF. 2009. Nipah virus sequesters inactive STAT1 in the nucleus via a P geneencoded mechanism. J. Virol. 83:7828-7841.
13. Devaux P, Cattaneo R. 2004. Measles virus phosphoprotein gene products: conformational flexibility of the P/V protein amino-terminal domain and C protein infectivity factor function. J. Virol. 78:11632-11640.
14. Devaux P, Hodge G, McChesney MB, Cattaneo R. 2008. Attenuation of V- or C-defective measles viruses: infection control by the inflammatory and interferon responses of rhesus monkeys. J. Virol. 82:5359-5367.
15. Eaton BT, Broder CC, Middleton D, Wang LF. 2006. Hendra and Nipah viruses: different and dangerous. Nat. Rev. Microbiol. 4:23-35.
16. Escoffier C, et al. 1999. Nonstructural C protein is required for efficient measles virus replication in human peripheral blood cells. J. Virol. 73: 1695-1698.
17. Garcin D, Marq JB, Strahle L, le Mercier P, Kolakofsky D. 2002. All four Sendai Virus C proteins bind Stat1, but only the larger forms also induce its mono-ubiquitination and degradation. Virology 295:256-265.
18. Glass WG, Rosenberg HF, Murphy PM. 2003. Chemokine regulation of inflammation during acute viral infection. Curr. Opin. Allergy Clin. Immunol. 3:467-473.
19. Goodbourn S, Randall RE. 2009. The regulation of type I interferon production by paramyxoviruses. J. Interferon Cytokine Res. 29:539-547.
20. Gotoh B, Komatsu T, Takeuchi K, Yokoo J. 2001. Paramyxovirus accessory proteins as interferon antagonists. Microbiol. Immunol. 45:787-800.
21. Gotoh B, Komatsu T, Takeuchi K, Yokoo J. 2002. Paramyxovirus strategies for evading the interferon response. Rev. Med. Virol. 12:337-357.
22. Guillaume V, et al. 2009. Acute Hendra virus infection: Analysis of the pathogenesis and passive antibody protection in the hamster model. Virology 387:459-465.
23. Gurley E, et al. 2007. Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg. Infect. Dis. 13:1031-1037.
24. Harcourt BH, et al. 2005. Genetic characterization of Nipah virus, Bangladesh, 2004. Emerg. Infect. Dis. 11:1594-1597.
25. Harcourt BH, et al. 2001. Molecular characterization of the polymerase gene and genomic termini of Nipah virus. Virology 287:192-201.
26. Harcourt BH, et al. 2000. Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology 271:334-349.
27. Hasan MK, et al. 2000. Versatility of the accessory C proteins of Sendai virus: contribution to virus assembly as an additional role. J. Virol. 74: 5619-5628.
28. Hermoso MA, Cidlowski JA. 2003. Putting the brake on inflammatory responses: the role of glucocorticoids. IUBMB Life 55:497-504.
29. Horikami SM, Hector RE, Smallwood S, Moyer SA. 1997. The Sendai virus C protein binds the L polymerase protein to inhibit viral RNA synthesis. Virology 235:261-270.
30. Horvath CM. 2004. Silencing STATs: lessons from paramyxovirus interferon evasion. Cytokine Growth Factor Rev. 15:117-127.
31. Hossain MJ, et al. 2008. Clinical presentation of nipah virus infection in Bangladesh. Clin. Infect. Dis. 46:977-984.
32. Hsu VP, et al. 2004. Nipah virus encephalitis reemergence, Bangladesh. Emerg. Infect. Dis. 10:2082-2087.
33. Jaffe EA, Nachman RL, Becker CG, Minick CR. 1973. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52:2745-2756.
34. Kato A, et al. 2007. Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice. J. Virol. 81:3264-3271.
35. Komatsu T, Takeuchi K, Yokoo J, Gotoh B. 2004. C and V proteins of Sendai virus target signaling pathways leading to IRF-3 activation for the negative regulation of interferon-beta production. Virology 325:137-148.
36. Leroy EM, et al. 2000. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 355:2210-2215.
37. Lo MK, et al. 2010. Characterization of the antiviral and inflammatory responses against Nipah virus in endothelial cells and neurons. Virology 404:78-88.
38. Marianneau P, et al. 2010. Experimental infection of squirrel monkeys with nipah virus. Emerg. Infect. Dis. 16:507-510.
39. Mathieu C, et al. 2012. Lethal Nipah virus infection induces rapid overexpression of CXCL10. PLoS One 7:e32157. doi:10.1371/journal-.pone.0032157.
40. Mathieu C, et al. 2011. Nipah virus uses leukocytes for efficient dissemination within a host. J. Virol. 85:7863-7871.
41. Mayo MA. 2002. A summary of taxonomic changes recently approved by ICTV. Arch. Virol. 147:1655-1663.
42. Nakatsu Y, Takeda M, Ohno S, Koga R, Yanagi Y. 2006. Translational inhibition and increased interferon induction in cells infected with C protein- deficient measles virus. J. Virol. 80:11861-11867.
43. Park MS, et al. 2003. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J. Virol. 77:1501-1511.
44. Patterson JB, Thomas D, Lewicki H, Billeter MA, Oldstone MB. 2000. V and C proteins of measles virus function as virulence factors in vivo. Virology 267:80-89.
45. Piqueras B, Connolly J, Freitas H, Palucka AK, Banchereau J. 2006. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 107:2613-2618.
46. Reynes JM, et al. 2005. Nipah virus in Lyle's flying foxes, Cambodia. Emerg. Infect. Dis. 11:1042-1047.
47. Rockx B, et al. 2011. Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection. J. Virol. 85:7658-7671.
48. Rodriguez JJ, Parisien JP, Horvath CM. 2002. Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J. Virol. 76:11476-11483.
49. Shaw G, Morse S, Ararat M, Graham FL. 2002. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J. 16:869-871.
50. Shaw ML, Cardenas WB, Zamarin D, Palese P, Basler CF. 2005. Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways. J. Virol. 79:6078-6088.
51. Shaw ML, Garcia-Sastre A, Palese P, Basler CF. 2004. Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively.J. Virol. 78:5633-5641.
52. Sleeman K, et al. 2008. The C, V and W proteins of Nipah virus inhibit minigenome replication. J. Gen. Virol. 89:1300-1308.
53. Stone R. 2011. Epidemiology. Breaking the chain in Bangladesh. Science 331:1128-1131.
54. Strahle L, Garcin D, Kolakofsky D. 2006. Sendai virus defectiveinterfering genomes and the activation of interferon-beta. Virology 351: 101-111.
55. Strahle L, Garcin D, Le Mercier P, Schlaak JF, Kolakofsky D. 2003. Sendai virus targets inflammatory responses, as well as the interferoninduced antiviral state, in a multifaceted manner. J. Virol. 77:7903-7913.
56. Takeuchi K, et al. 2005. Stringent requirement for the C protein of wild-type measles virus for growth both in vitro and in macaques. J. Virol. 79:7838-7844.
57. Valsamakis A, et al. 1998. Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J. Virol. 72:7754-7761.
58. Virtue ER, Marsh GA, Baker ML, Wang LF. 2011. Interferon production and signaling pathways are antagonized during henipavirus infection of fruit bat cell lines. PLoS One 6:e22488. doi:10.1371/journal.pone.0022488.
59. Virtue ER, Marsh GA, Wang LF. 2011. Interferon signaling remains functional during henipavirus infection of human cell lines. J. Virol. 85: 4031-4034.
60. Wong KT, et al. 2003. A golden hamster model for human acute Nipah virus infection. Am. J. Pathol. 163:2127-2137.
61. Wong KT, et al. 2002. Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am. J. Pathol. 161:2153-2167.
62. Yoneda M, et al. 2006. Establishment of a Nipah virus rescue system. Proc. Natl. Acad. Sci. U. S. A. 103:16508-16513.
63. Yoneda M, et al. 2010. The nonstructural proteins of Nipah virus play a key role in pathogenicity in experimentally infected animals. PLoS One 5:e12709. doi:10.1371/journal.pone.0012709.